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GENERAL INTRODUCTION 
Behavioral and cellular modifications in learning and memory 
Organisms must be capable of continually modifying their behavior in response to a 
changing environment Changes in the brain, or more specifically, changes in synapses are 
widely believed to underlie changes in behavior. That is, synaptic plasticity is thought to 
underlie behavioral plasticity. Synaptic plasticity can be brought about fix>m changes at many 
levels. Synapses may vary their function, be replaced, increase or decrease in number, and 
sprout or prune their axonal branching patterns. Synaptic connections are formed and broken 
continuously throughout life (Cotman and Nieto-Sampedro, 1984). Systems in which to study 
the synaptic mechanisms underlying the processes of learning and memory following either 
behavioral or electrophysiological conditioning are available. 
In the nervous system, neurons communicate primarily through chemical synapses. A 
chemical neurotransmitter is released by the presynaptic cell that activates receptors on the 
postsynaptic neuron. An ion conductance change in the postsynaptic membrane may result in a 
change in the postsynaptic potential. The efficacy of synaptic transmission can be influenced 
by the presynaptic neuron's electrophysiological history or by neuromodulators released from 
nearby nerve terminals. In the early part of the twentieth century, Cajal proposed that learning 
and memory arise fitom changes in the strength of synaptic transmission (Cajal, 1911). Short-
term changes in the synapse may last for minutes. The presynaptic neuron may vary the 
amount of neurotransmitter released or the postsynaptic neuron may modify its response to a 
given amount of transmitter. This may be the cellular correlate of learning and memory. 
Long-term changes in the synapse may last for hours or days and may underlie memory. 
Persistent changes in biochemistry, morphology, and gene expression may occur in 
presynaptic and postsynaptic neurons. 
There is a great deal of interest in determining the basic mechanisms of learning but only 
recently have these mechanisms begun to be studied at the cellular level In part, this has been 
made possible by the use of invertebrates as model systems. Some invertebrate preparations 
are valuable as model systems in that all behavioral functions are controlled by simple nervous 
systems with ganglia containing relatively small numbers of large cells (Kandel and Schwartz, 
1982). These neurons can be consistendy identified in virtually all preparations. Once the 
neuronal architecture is known, it becomes possible to determine systematically which neurons 
are responsible for the behavior under investigation. Once the neurons exhibiting plasticity are 
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known, it is possible to identify changes in their structure and function that are responsible for 
the observed changes in behavior. These studies have identified many processes underlying 
the net change in synaptic strength including changes in ion conductances, GTP-binding 
proteins (G proteins), second messengers, protein kinases, and mobilization of synaptic 
vesicles. One organism that is widely used to study subcellular changes is the invertebrate 
marine mollusc, Apfysia (Kandel and Schwartz, 1982). Another approach is to study the 
mammalian hippocampus, an area of the brain known to be involved in learning (Bliss and 
Lomo, 1973; Bliss and Gardner-Medwin, 1973). Experiments in both of these systems have 
produced evidence that there are specific changes at the level of the ^napse that possibly 
underlie the modification of behavior. 
Through studies in Aplysia during the last few decades, it appears that both learning and 
memory are due to changes in neural connections (Castellucci et al., 1970; Hawkins et al., 
1983; Kandel et al., 1986). Simple forms of learning may have cellular correlates at synapses 
between specific neurons. A simple reflex, the gill withdrawal reflex, in Aplysia can be 
modified by a form of nonassociative learning, sensitization. This is a form of short-term 
memory that is a nonspecific enhancement of a response. If a noxious sensitizing stimulus is 
delivered prior to a weak stimulus, the animal will retract more vigorously than if the weak 
stimulus is delivered alone. 
Critical synaptic changes underlying sensitization have been intensely investigated. 
Presynaptic facilitation of synaptic transmission at the sensory-motor neuron synapse is 
involved. Application of the neurotransmitter serotonin mimics the sensitizing stimulus by 
eliciting presynaptic facilitation, a short-term increase in transmitter release, from the sensory 
neuron (Brunelli et al., 1976). The modulation of ion conductances by second messengers 
contributes to this process. In sensory neuron somata, serotonin causes the closure of a novel 
class of potassium channels called the "S" (serotonin-sensitive) channels (Klein et al., 1982). 
This action on the potassium channels is mediated by an increase in cAMP levels that then 
activates cAMP-dependent protein kinase (Klein et al., 1982; Siegelbaum et al,, 1982; Shuster 
et al., 1985). The channels have a decreased probability of opening upon exposure to 
serotonin or injection of cAMP (Scholz and Byrne, 1988). This reduced potassium 
conductance leads to enhanced action potential duration in the somata, a greater influx of 
calcium, and a facilitation of transmitter release. The overall effect of serotonin is thought to 
underlie sensitization. 
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The same reflex in Apfysia can undergo behavioral inhibition after a different training 
paradigm (Mackey et al., 1987). Studies to elucidate the underlying synaptic mechanisms 
indicate that there is a hyperpolarization of the sensory neurons, a decrease in the action 
potential duration, and a reduction in synaptic transmission from sensory neurons to follower 
cells. These modifications aie mimicked by application of the neuropeptide FMRFannde. This 
modulator causes a presynaptic inhibition of transmitter release in sensory neurons through 
lipoxygenase metabolites of arachidonic acid (PiomeUi et al., 1987). FMRFamide has dual 
effects on the "S" channels. It causes an increase in the probability of opening of the channels 
and reverses the closures of the channels previously modulated by serotonin (Belardetti et al., 
1987). FMRFamide has also been found to decrease the magnitude of calcium currents 
(Colombaioni et al., 1985; Brezina et al., 1987; Kramer et al., 1988). Together, these actions 
lead to a decrease in action potential duration, decreased influx of calcium, and a reduction in 
transmitter release. 
Modulation of pre-existing synapses has also been observed in the hippocampus. The 
hippocampus is a region of the brain that exhibits both morphological and functional plasticity. 
It has previously been proposed to be a site involved in the location of memory sorting based 
on observations of severe memory impairment in humans after bilateral lesions of the 
hippocampal region (Scoville and Milner, 1957). Long-term potentiation (LTP) is an 
enhancement of synaptic strength in the hippocampus following repeated use. To study 
synaptic changes involved in LTP, the hippocampus is cut into thin slices such that each slice 
contains many layers of the entire circuit involved. LTP can be elicited by brief (1 second or 
less) tetanic stimulation of a sufficient intensif to coincidentally activate a critical number of 
presynaptic fibres. There are two distinct stages that are necessary for LTP to occur, induction 
and expression (Bliss and Lynch, 1988; Nicoll et al., 1988). Induction is the trigger necessary 
for the establishment of LTP and expression is the maintenance of enhanced synaptic efficacy. 
The neurotransmitter released from the presynaptic terminals is thought to be glutamate. 
After diffusing across the synaptic cleft, glutamate binds to several types of receptors present 
in the postsynaptic membrane. A subclass of glutamate receptors, the NMDA receptors, has 
an unusual property. At resting membrane potentials, the ion channel associated with the 
receptor is blocked by magnesium ions. If the postsynaptic membrane is depolarized in the 
presence of glutamate, the magnesium block is removed (Nowak et al., 1984). Glutamate 
binding to the NMDA receptors now allows the flow of calcium ions into the postsynaptic 
cytoplasm (Mayer et al., 1987). This entry of calcium is a cmcial event in the induction of 
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LTP. Several lines of evidence indicate that protein kinase C and calcium/calmodulin-
dependent protein kinase are involved in the induction process (Malenka et al., 1986; Hu et al., 
1987; Malenka et al., 1989; Malinow et al., 1989). A third protein that is thought to be 
involved in the induction process is the calcium-activated protease, calpain L It has been 
hypothesized that the protease may hydrolyze enzymes such as the kinases mentioned above, 
rendering them constitutively active (Siman and Noszek, 1988). In addition to enzyme 
involvement in the induction of LTP, evidence suggests that a pertussis toxin-sensitive G 
protein that is not located in the postsynaptic neuron is another required component LTP 
could not be induced in hippocampus slices that had been pretreated with pertussis toxin. This 
G protein appears to be upstream of protein kinase C in that activation of the kinase could still 
induce LTP even though the G proteins had been previously inactivated. 
Once LTP has been successfully induced, enhanced synaptic transmission is maintained on 
a long-term basis, on the order of hours and weeks. Evidence suggests that it is the 
presynaptic terminal that is involved in the maintenance phase by releasing greater quantities of 
glutamate. Two recent studies have used new techniques of patch clamping the presynaptic 
neurons in hippocampal slices. With these techniques, LTP could be recorded with an 
improved signal-to-noise ratio that allowed for a quantal analysis to be performed (Bekkers and 
Stevens, 1990; Malinow and Tsien, 1990). This type of statistical analysis demonstrated that 
the probability of transmitter release is increased during LTP pointing to a presynaptic locus of 
expression. Although this type of analysis provided evidence of a change occurring in the 
presynaptic neuron, an increase in postsynaptic responsiveness could not be ruled out in these 
studies. 
Morphological modifications 
Using electron microscopy, studies of moiphological changes in the hippocampus 
following learning have recentiy begun. In the brain, synapses occur on spines that project 
from the dendrites rather than on dendritic shafts. Using high speed fteeze-fîxing techniques, 
the size of spines has been shown to increase when their synaptic contacts are jactivated. This 
may cause a decrease in the electrical resistance between the spine and its parent dendrite 
(Gray, 1987). Two theories have been proposed to account for the spine swelling: a 
contractile actin cytoskeleton within the spine cytoplasm remodels the spine; and/or osmotically 
active substances build up in the spine during stimulation that then produces an intake of water 
from the extracellular compartment, thus swelling the spine. In another study, Lee et al. 
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(1980) found that there were 30% more synaptic contacts found on dendritic shafts of 
potentiated neurons after induction of LTP. 
Morphological correlates have been observed to develop at the level of the synapse in 
Aplysia (Bailey and Chen, 1988a). The connections between sensory and motor neurons are a 
critical locus for memory storage. The modulation of synapse number may be important in the 
maintenance of long-term memory. In studies examining presynaptic terminals. Bailey and 
Chen (1988a) found that the total number of presynaptic varicosities had decreased in animals 
that had undergone behavioral inhibition and had increased in sensitized animals. In addition, 
there were enlarged neuropil arbors observed in sensitized animals (Bailey and Chen, 1988a). 
In further studies. Bailey and Chen (1988b) determined that long-tenn sensitization also alters 
the structure of the postsynaptic motor neuron by increasing the surface area of the motor 
neuron that was occupied by synaptic contacts. 
Subcellular mechanisms 
There are many cases of neurotransmitters exerting their actions through G proteins. 
Accordingly, the role of G proteins in the actions of serotonin and FMRFamide on the K+ 
channels was determined in Aplysia (Volterra and Siegelbaum, 1988). The effect of 
FMRFamide on the K+ channels was mediated through a pertussis toxin-sensitive G protein. 
This G protein may be involved in an early stage of arachidonic acid metabolism that is coupled 
to channel modulation. There is another G protein, most likely related to Gg, that couples 
serotonin to stimulation of adenylate cyclase. 
Neuronal calcium channels serve many functions (reviewed in Miller, 1987). Accordingly, 
there are multiple types of calcium channels and their subcellular localization may optimize their 
effectiveness. The types of calcium channels with distinct electrophysiological and 
pharmacological profiles that are found in the plasma membrane vary from cell to cell 
depending on the particular functions that calcium plays in that cell. Calcium functions as a 
second messenger in the cell and events that are controlled by calcium entry through voltage-
gated calcium channels include enzyme activation, metabolism, gene expression, neurite 
outgrowth, and transmitter release. Dorsal root ganglion neurons contain three main channel 
types based on their electrophysiological and pharmacological profiles (Nowicky et al., 1985). 
The L-type channels are thought to cause the release of substance P &om dorsal root ganglion 
neurons (Pemey et al., 1986; Rane et al., 1987). However, in other systems it appears that the 
N-type current is responsible for triggering transmitter release (Pemey et al., 1986; Himing et 
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al., 1988). Modulation of the calcium current involved in release is one means of causing 
presyn^tic facilitation or depression of transmitter release. 
There are many neurotransmitters that modulate calcium currents and many act through a G 
protein cither through its direct action on calcium channels or through second messenger 
systems. The involvement of a G protein has been demonstrated with the use of guanine 
nucleotide analogues, antibodies, and pertussis toxin. 
Noradrenaline was the first transmitter found to modulate calcium channels in cultured 
cardiac cells (Cachelin et al., 1983). Through B-adrenergic receptors, noradrenaline is coupled 
to Gs that activates adenylate cyclase. The increased levels of cAMP then activate cAMP-
dependent protein kinase that phosphorylates channels. The gating kinetics of the channels are 
changed such that there is an increase in the macroscopic calcium current Other 
neurotransmitters act through G proteins to activate phospholipase C and phospholipase A2. 
Some studies have shown that G proteins directly modulate channel activity (for example, 
Cantau et al., 1980; Yatani et al., 1987; Volterra and Siegelbaum, 1988; Imoto et al., 1988; 
Kim et al., 1989; reviewed in Dolphin, 1990). In addition to noradrenaline modulating a 
calcium current, a number of other neurotransmitters have modulatory effects on calcium 
currents through G proteins in a variety of systems. Several studies have shown that a 
pertussis toxin-sensitive G protein is able to couple inhibitory neurotransmitters to calcium 
channels in chick and rat dorsal root ganglion neurons (Holz et al., 1986; Ewald et al., 1988; 
Ewald et al., 1989), neuroblastoma X glioma hybrid cells (Hescheler et al., 1987), AtT-20 
pituitary cells (Lewis et al., 1986), rat sensory and sympathetic neurons (Dolphin and Scott, 
1987; Wanke et al., 1987), and Helix neurons (Harris-Wanick et al., 1988). 
Dissertation experiments 
The present studies have used a model system of cultured somatic synapses &om the 
freshwater pond snail Helisoma trivolvis to investigate subcellular changes underlying synaptic 
plasticity. This organism was initially chosen for neurobiological studies because of its 
definable behavior and accessible nervous system. As in Aplysia, Helisoma ganglia contain a 
relatively small number of large neurons within its nervous system. Individual neurons can be 
visually identified for all members of the species based on the cells' relative position within the 
ganglia, pigmentation, size, and axonal geometry. Experiments performed in culture 
conditions have the advantage of allowing the investigator full control over the intracellular and 
extracellular environments of the neurons. The cell bodies of the neurons comprise the 
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periphery of the ganglia. This configuration aids in the removal of specific neurons fiom the 
ganglionic environment to be transferred into a culture environment 
In general, previous studies of "classic" synapses have been hampered by the small size of 
and the lack of electrophysiological access to the presynaptic terminal To overcome this 
shortcoming, a system of "giant" synaptic terminals has been developed to investigate 
mechanisms underlying synapse formation and synaptic plasticity (Haydon, 1988). When 
cultured in the presence of Helisoma hemolymph, the neurons do not extend neurites, retain a 
spherical geometry, and readily adhere to one another. The large size (60 pM diameter) and 
spherical shape of the neurons allow for direct electrophysiological access to both the 
presynaptic and postsynaptic cells. When the cell bodies of identified buccal neurons 5 and 19 
(B5 and B19) are in contact, a unidirectional cholinergic synapse forms between the two 
somata with neuron B5 assuming the role of the presynaptic terminal. 
With this unique system, synaptic plasticity and the subcellular mechanisms underlying this 
process can be studied at an increased resolution. During regulated secretion fiom neurons, 
vesicles line up adjacent to the plasma membrane. When the appropriate signal (an action 
potential) reaches the presynaptic terminal, there is an increase in the level of intracellular 
calcium due to the opening of voltage-sensitive calcium channels. The calcium channels are 
probably situated 10 to 20 nm away firom the vesicles (Aimers, 1990). In a short period of 
time, several events following the action potential must occur in the presynaptic neuron to 
promote neurotransmitter release: the calcium channels must open to admit calcium into the 
nerve terminal, the level of calcium in the region surrounding the vesicles must increase, 
calcium must bind to a receptor, the receptor must change conformation, and membrane fusion 
must occur to release the neurotransmitter (Aimers, 1990). Many of these events involve the 
seaetory machinery (or secretory apparatus). The components composing the secretory 
machinery are not well identified but are assumed to be made up of vesicles containing 
neurotransmitter, the calcium receptor, and a family of synaptic proteins associated with the 
vesicles and/or the plasma membrane. 
Using the "giant" Helisoma synapses, the calcium currents of secretory membranes can be 
analyzed with voltage clamp techniques. Additionally, using a photolabile calcium chelator to 
promote secretion &om the presynaptic neuron, the secretory apparatus can be studied 
independently of the voltage-sensitive calcium channels. In this manner, changes in ion 
conductances and secretory machineiy during synaptic plasticity can be investigated separately. 
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Finally, macromolecules can be dialyzed or injected into the somata to test for the involvement 
of G proteins and second messengers. 
FMRFamide is a moUuscan neuropeptide (Greenberg and Price, 1983) that has been 
reported to reduce calcium currents (Colombaioni et al., 1985; Brezina et al., 1987; Kramer et 
al., 1988) and increase potassium currents (Colombaioni et al., 1985; Belardetti et al., 1987). 
FMRFamide and two analogues, FLRFamide and GDPFLRFamide, are abundant in Helisoma 
nervous tissue (Bulloch et al., 1988). FMRFamide causes inhibition of synaptic transmission 
(Man-Son-Hing et al., 1989) by an inhibitory action solely in the presynaptic terminal (Zoran 
et al., 1989). FMRFamide has dual actions within the presynaptic neuron. My studies have 
focussed on: 1) the reduction of the secretoiy machinery's sensitivity to calcium and the 
macroscopic calcium current modulation by FMRFamide and 2) the involvement of a pertussis 
toxin-sensitive G protein in the reduction of the calcium current and the effect of G protein 
injection on the calcium current 
Explanation of dissertation format 
This dissertation is composed in the alternate format Each of the sections is a complete 
manuscript modified to conform to the specifications of the Iowa State University Thesis 
Office. Each section has its own introduction, materials and methods, results, discussion, and 
references. A general summary follows Section 2 and discusses the entire body of work. 
9 
SECTION 1. FMRFamide ACTS PRESYNAPTICALLY TO INHIBIT SYNAPTIC 
TRANSMISSION: MODULATION OF A CALCIUM CURRENT AND 
SECRETORY MACHINERY 
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INTRODUCTION 
In neurons, vesicles collect in the active zone, a region adjacent to the presynaptic plasma 
membrane. An action potential causes an influx of calcium through voltage-sensitive calcium 
channels that may also be clustered in the active zone. The influx of calcium across the plasma 
membrane results in a localized increase in the level of intracellular &ee calcium (Smith and 
Augustine, 1988). This rise in calcium is sufficient to trigger exocytosis of neurotransmitter 
(Katz, 1969). 
Neuromodulators use multiple mechanisms to modulate synaptic transmission. Targets of 
neuromodulators include neurotransmitter receptors in the postsynaptic neuron and voltage-
sensitive ion channels and the secretory apparatus of the presynaptic terminal. For example, 
quantal analysis of LTP in the Schaffer collateral pathway in the hippocampus indicated that the 
expression of LTP is manifested by a change in quantal size that is consistent with an alteration 
in the sensitivity of postsynaptic receptors (Bliss, 1990). Additionally, Davies et al. (1989) 
demonstrated that postsynaptic sensitivity of CAl neurons to exogenously-applied 
neurotransmitter increased following induction of LTP. Neuromodulators can also target the 
presynaptic neuron. A presynaptic locus was found during the initial half hour following LTP 
induction (Davies et al., 1989). In separate studies, quantal analysis of LTP in the CAl region 
of the hippocampus pointed to a presynaptic locus of LTP expression (Bekkers and Stevens, 
1990; Malinow and Tsien, 1990). Modulation of potassium and calcium channels in the 
presynaptic terminal alters the duration of the action potential, changes the amount of calcium 
entering the cytoplasm and thus, modulates the amount of neurotransmitter released. For 
example, during the cellular correlate of sensitization in Aplysia, there is an increase in the 
amount of transmitter released from the presynaptic terminal after the application of serotonin. 
This effect is partly due to a decrease in a potassium conductance that is mediated by an 
increase in cAMP levels (Klein et al., 1982; Siegelbaum et al., 1982; Shuster et al., 1985). 
The longer duration of the action potential, that results from the reduced potassium current, 
allows a greater influx of calcium into the cytoplasm that, in turn, causes a facilitation of 
transmitter release. In contrast, FMRFamide causes a decrease in action potential duration, 
decreased influx of calcium, and a reduction in transmitter release. FMRFamide has dual 
effects on the serotonin-sensitive potassium channels and calcium channels (Colombaioni et 
al., 1985; Belardetti et al., 1987; Brezina et al., 1987; Kramer et al., 1988). It causes an 
increase in the probability of opening of the potassium channels and reverses the closures of 
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the channels previously modulated by serotonin. In frog sympathetic neurons, catecholamines 
reduce the amount of neurotransinitter released by modulating a specific type of calcium 
current, the N-type current (Lipscombe et al., 1989) 
In addition to affecting ion channels, there are other means of modulating secretion. For 
example, in nonneural cells, G proteins and second messengers can modulate the sensitivity of 
the secretory apparatus to the level of internal free calcium (reviewed in Gomperts, 1990). The 
physiology of exocytosis has been studied extensively in mast cells (for example, Bennett et 
al., 1981; Gomperts et al., 1983; Fernandez et al., 1984; Howell et al., 1987; Howell and 
Gomperts, 1987; Sorimachi et al., 1987; Sorimachi et al., 1988). Both calcium and guanine 
nucleotides are essential for the process of degranulation to occur (Howell et al., 1987). 
Together, they are sufficient to cause a maximal exocytotic event (Howell et al., 1987). This 
process can be modulated. In the presence of ATP, the concentrations of calcium and guanine 
nucleotide required to induce exocytosis are significantly reduced (Howell et al., 1987). 
Additionally, the calcium receptor's affinity for calcium and the G protein's (termed GE) 
affinity for guanine nucleotide are controlled by phosphorylation by protein kinase C (Howell 
et al., 1988). 
Other non-neural systems have been studied with respect to the modulation of secretion. In 
platelets, calcium alone can trigger exocytosis but the presence of GTP analogues enhances the 
affinity for calcium such that exocytosis of amines occurs at calcium concentrations below 
physiological resting levels (Haslam and Davidson, 1984). At very high levels of GTP 
analogues, calcium-independent secretion can occur. Individually, calcium and guanine 
nucleotides stimulate secretion &om neutrophils (Barrowman et al., 1986). Together, their 
effects on secretion are additive. In HL-60 cells, exocytosis will occur with any two of 
calcium, guanine nucleotides, andphorbol ester (Snutchfield and Cockcroft, 1988). 
In neural cells, it has been suggested that the secretory machinery can be regulated. In 
studies performed by Dale and Kandel (1990), serotonin increased and FMRFamide decreased 
the firequency of spontaneous miniature excitatory postsynaptic potentials firom sensoiy 
neurons. This modulation by both neurotransmitters occurred in external solutions that lacked 
calcium and contained calcium-chelating agents. Additionally, modulation occurred in 
solutions containing cadmium, a calcium channel blocker. Finally, modulation occurred when 
BAPTA, a calcium chelator, was injected into the presynaptic terminal. These results suggest 
that modulation of spontaneous release does not require an elevation of intracellular calcium 
and is due to the effects on the secretory machinery. In the squid giant synapse, the state of 
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phosphorylation of a protein associated with secretory vesicles, synapsin I, regulates the 
magnitude of the postsynaptic potential in response to a constant calcium current (Llinas et al., 
1985). From these studies in neurons and in non-neural cells, it appears that both ion channels 
and secretory apparatus can be targets of modulation. 
FMRFamide is a peptide endogenous to many molluscs (Greenberg and Price, 1983) and 
has widespread effects in moUuscan systems. For example, FMRFamide has inhibitory effects 
on feeding behavior (Murphy et al.,1985) and digestive tract motility (Lehman and Greenberg, 
1987), and cardioexcitatory effects (Lehman and Greenberg, 1987). On the cellular level, 
FMRFamide modulates ion currents and spontaneous release (Colombaioni et al., 1985; 
Belardetti et al., 1987; Brezina et al., 1987; Kramer et al., 1988; Dale and Kandel, 1990). The 
goal of the present studies was to use the increased resolution made possible with giant 
synapses from Helisoma to examine the effects of FMRFamide on synaptic transmission. 
Specifically, the effects of FMRFamide on the calcium currents and the secretory machinery in 
the presynaptic neuron were investigated. 
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MATERIALS AND METHODS 
Cell culture 
Neuron isolation All e^geriments were performed on adult specimens of the ORl strain 
of the pond snail Helisoma trivolvis. The animals were maintained in laboratory aquaria at 22 
to 250c and fed trout chow and lettuce. The snails were deshelled by cutting the shell 
perpendicular to the whorl. The animals were placed into a solution of 25% Listerine in 
antibiotic saline (ABS; Table 1; Wong et al., 1981) for 10 minutes. 
During the dissection, the snails were bathed in ABS and pinned ventral side down in a 
silicon rubber (Sylgard 182 silicon; Dow Coming, Midland, MI) coated petri dish. An 
incision was made on the dorsal side 60m the mantle to the level of the tentacles. The sides of 
the animal were pinned to expose the underlying nervous system. The paired buccal ganglia 
with a piece of the esophagus were isolated and placed into ABS. The ganglia were treated 
with a 0.2% solution of trypsin (Sigma Chemical Company; Type HI) in defined medium (DM; 
Table 1; Wong et al., 1981) for 20 to 25 minutes. 
The enzymaticaUy-treated ganglia were pinned in a dissecting dish. A small cut was made 
in the connective sheath overlying the neuron of interest with an electrolytically-shaipened 
tungsten microknife. The neuron was removed from the ganglion with suction from a fire-
polished glass pipette (100 jiM tip diameter). The isolated neurons were temporarily held in a 
35 mm petti dish (#1008 Falcon dish) containing 2 ml of a 1% solution of Helisoma 
hemolymph in DM (hemolymph extraction is discussed below). Placement of the cells in this 
solution prevents adherence to the substratum (Haydon, 1988). 
Culture dishes The cells were plated into 50 |il culture wells containing 10% unfiltered 
snail hemolymph (see below). The well was made by drilling a hole (5 mm diameter) in the 
bottom of a Falcon #1008 petri dish. A glass coverslip was attached to the bottom of the dish 
using a silicon seal (Weller silicone rubber adhesive sealant). The rubber was allowed to 
harden for 24 hours. The dishes were then soaked in distilled water for 48 hours to remove 
acetic acid. The culture wells were sterilized by soaking in 70% ethanol until the alcohol 
evaporated. 
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Hemolvmph extraction Neurite extension was prevented by culturing the neurons in a 
nonadhesive environment Unfiltered Helisoma hemolymph prevented adhesion and 
subsequent neurite extension; thus, neurons maintained a spherical geometry (Haydon, 1988). 
The hemolymph was extracted on each day of culture. Intact snails were subjected to a 
series of antiseptic washes. Hrst, the snails were soaked in ABS for 15 minutes. This was 
followed by a 15 minute incubation in a 1:3 Listerine:ABS solution. Finally, the snails were 
returned to ABS for 15 minutes. A small piece of the shell was removed to expose the foot 
and mucus was wiped off with a sterile cotton ball. The foot was pierced with the tips of a pair 
of forceps (Dumoxel #5) and the hemolymph, that flowed out of the foot, was collected in 
sterile capillary tubes. The hemolymph was centrifuged (International Hematocrit Centrifuge) 
for 5 minutes to remove noncellular debris. The culture medium contained a 10% hemolymph 
solution made up of 8 pi hemolymph and 72 |il DM. Individual neurons were plated into the 
culture wells. If single neurons were required for calcium current experiments, the neurons 
were plated at a distance from each other in the well. If synapses were to be studied, buccal 
neurons 5 and 19 were made to contact in the well. The cells adhered to one another for the 
duration of the culture period but not to the substratum. The synaptic pairs do not extend 
neurites and physical contact is made directly between the somata (Haydon, 1988). The 
neurons were transferred daily into new culture wells containing fresh medium and 
hemolymph. 
Electrophvsiologv 
The neurons were immobilized for electrophysiological recordings by plating them into a 
Falcon #1008 petri dish or a 12 mm culture well with a poly-L-lysine coated coverslip. The 
poly-L-lysine solution was made using 1 mg poly-L-lysine hydrobromide (Type VI; Sigma) in 
1 ml of 0.15 M Tris, pH 8.4. This solution was pipetted into each well and allowed to 
incubate for several hours. The wells were then rinsed twice with distilled water and air dried. 
Svnapses The culture wells were filled with DM or 1 jiM FMRFamide in DM during 
electrophysiological recordings from synapses. Throughout the study of synapses, 
postsynaptic neurons were voltage clamped using Dagan Corporation 8900 patch amplifiers. 
Postsynaptic pipettes were made using the standard two-step pulling technique with a 
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Narashige PP-83 patch pipette puller. The pipettes contained (in mM): 50 KCl, 5 MgCl2,5 
EGTA, 5 K+HEPES, pH 7.3 and typically had resistances of 4 MA. 
Action potentials were evoked in the presynaptic neuron using microelectrodes with 
resistances of 10 to 40 MG when filled with 1.5 M KCl. The microelectrodes were connected 
to a Getting Model 5A amplifier. To quantify the effect of FMRFamide on action potential-
evoked release, the experiment was divided into three periods; before the addition of 
FMRFamide, in the presence of FMRFamide, and following washout of FMRFamide. Before 
addition of FMRFamide, the amplitude of the three evoked postsynaptic currents (PSCs) were 
averaged and normalized to a value of 1.0. The amplitude of the three PSCs in the presence of 
FMRFamide, and the three PSCs following washout of FMRFamide were averaged and 
conçared to the control value of 1.0. 
Since spontaneous miniature postsynaptic currents (MPSCs) were the quantal events 
underlying action potential-evoked PSCs, asynchronous release of MPSCs was studied to 
determine the locus of FMRFamide action. Patch pipettes were used to voltage clamp the 
presynaptic neuron. Pipettes contained a solution similar to the postsynaptic solution that 
contained 35 mM CsCl instead of KCl plus 5 mM ATP and 1 mM OTP and had resistances of 
approximately 2 MO. A set of three depolarizing steps was delivered at 30 second intervals in 
each of three conditions: before the addition of FMRFamide, in its presence, and following 
washout The number of MPSCs was counted in each of the depolarizing periods. For all 
synapses, the number of MPSCs in the period before addition of FMRFamide was averaged 
and normalized to a value of 1.0. The numbers of MPSCs counted in the presence of 
FMRFamide and after washout were also averaged and compared to the control value of 1.0. 
Nitr-5 Photolytically-released calcium was used to trigger secretion to examine the effects 
of FMRFamide on the secretory apparatus. The presynaptic patch pipette contained: 20 mM 
nitr-5,18 mM CaCl2,35 mM KCl, 5 mM MgCl2,5 mM ATP, 1 mM OTP, 400 pM fura-2,5 
mM K+HEPES, pH 7.3. Fura-2 is a reliable means of monitoring the level of internal Aee 
calcium. The background intensity of the cells was measured before loading with fura-2 and 
was subtracted from all subsequent measurements. The fluorescent emission from fura-2 was 
collected at 510 nm with a photomultiplier. The emission intensities at 340 nm and 380 nm 
excitation were recorded using the UMANS system (Chester M, Regen Ph.D., Urbana, IL). 
A concentration of 20 mM nitr-5 (Calbiochem; Adams et al., 1988) was loaded to 90% 
capacity with 18 mM calcium. Adequate dialysis of the presynaptic neuron was judged as an 
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increase in the background rate of transmitter release. At this point, photolysis was performed 
to raise the level of intracellular free calcium. 
Nitr-5 is synthesized by the introduction of a photolabile group into the chelator BAPTA 
(Adams et al, 1988). Photolysis of nitr-5 yields compounds with affinities for calcium that aic 
lower than the precursor molecule. Exposure to ultraviolet light causes the conversion of a 2-
nitroben:^! moiety to a 2-nitroso stmcture. A water molecule is ejected and a ketone residue 
replaces the original alcohol group. Preceeding ultraviolet illumination, nitr-5 has a Kd for 
calcium of 0.145 p.M and following photolysis, the Kj changes to 6.3 jiM resulting in an 
irreversible release of calcium into the cytoplasm. 
A Nikon diaphot inverted microscope with a 40X oil immersion objective was used to view 
the synaptic pairs. After the presynaptic neuron was dialyzed with the nitr-5-containing 
solution for 1 to 5 minutes, the rate of release of ACh increased. The calcium was then 
released from its cage by light provided by a 75 watt Xenon arc lamp and passed through a 340 
nm band pass filter and a 400 nm dichroic mirror. The ultraviolet light was focussed onto the 
neuron through the 40X oil immersion objective. In most experiments, the intensity of 
illumination was decreased by a 17% transmittance neutral density filter. 
The rate of transmitter release was determined by measuring the reciprocal of the interval 
between each postsynaptic event The variability in graphing the instantaneous release rate was 
reduced by averaging each interval with the moving bin method (Rahamimoff and Yaari, 
1973). The value from each interval was averaged with the values from the intervals 
immediately before and after. The rate of postsynaptic currents was also calculated by 
measuring the average rate over a 3 second interval. 
Calcium currents The calcium currents of secretory neurons were studied using standard 
voltage clamp techniques. The neurons were transferred to a Falcon #1008 culture dish to 
immobilize them for electrophysiological recordings. Calcium currents were 
pharmacologically and ionically isolated for study with a standard external saline consisting of 
(in mM): 0 NaCl, 4.1 CaCl2,1.5 MgCl2,1.7 KCl, 30 tetraethylammonium Br, 10 4-
aminopyridine, 30 sucrose, and 10 HEPES, pH 7.3. Presynaptic pipettes had resistances of 2 
MO when filled witii (in mM): 35 CsCl, 5 MgCl2,5 EGTA, 5 ATP, 1 OTP, 5 K+HEPES, 
pH 7.3. 
Neurons were voltage clamped using a Dagan 8900 patch clamp amplifier and signals were 
filtered with a comer ôequency of 1 kHz. In all figures, leakage and capacitative currents have 
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been digitally subtracted using appropriately scaled hyperpolarizing pulses. Series resistance 
condensation was employed. Voltage clamp experiments and analyses were performed using 
pClamp software (Axon Instruments, CA). 
When the effect of FMRFamide (Bachem) on the calcium current was studied, a standard 
stimulus paradigm was used. Neurons were repetitively depolarized at 30 second intervals for 
nine episodes fix>m a holding potential of -60 mV to a command potential that evoked the 
maximnm current in an individual cell. The current magnitude was monitored for three 
depolarizations in standard external saline to ensure the stability of the current If the calcium 
current decreased by > 5% in this time period, analysis of the cell was terminated. If the 
current remained stable, the average magnitude of the control HVA current evoked by the three 
depolarizations was assigned a value of 1.0. The mean peak calcium current from three 
dq}oIarizations in 1 piM FMRFamide, and the mean peak current from three depolarizations 
following washout of the peptide, were calculated and normalized to the control value of 1.0. 
Significant differences were tested using 1- and 2-tailed student's t-tests. The values 
expressed are the mean + s.e.m. unless otherwise stated. Typically, 1 pM FMRFamide was 
used throughout the experiments. 
The micropipettes and patch pipettes were manipulated using Narishige micromanipulators. 
The membrane currents were displayed on a Tektronix 5111 storage oscilloscope and on a 
Gould 220 chart recorder. 
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Table 1. Contents of salines and medium 
ABS DMa 
inmM inmM 
NaCl 51.3 40.0 
CaCl2 4.1 4.1 
KQ 1.7 1.7 
MgCl2 1.5 1.5 
HEPES 10,0 10.0 
Gentamydn Sulfate (Sigma) 150 |ig/ml 50|ig/ml 
L-Glutamine (Gibco) 0.15 mg/ml 
L-15 (Leibovitz) (see Table 2) 50% 
^DM is filtered through a 0.45 |im filter unit (Nalgene). 
Table 2. Contents of L-15 Medium 
L-15 (Leibovitz) Medium 
50% dilution inmM 
D (+) Galactose 2.5 
Phenol red 0.01 
Sodium pyruvate 2.5 
Amino acids: inmM 
DL-a-Alanine 2.5 
L-Arginine (free base) 1.44 
L-Asparagine 0.95 
L-Cysteine (free base) 0.50 
L-Glutamine 1.03 
Glycine 1.33 
L-Histidine (free base) 0.81 
DL-Isoleucine 0.95 
L-Leucine 0.48 
L-Lysine (free base) 0.26 
DL-Methionine 0.50 
DL-Phenylalanine 0.76 
L-Serine 0.95 
DL-Threonine 2.52 
L-Tryptophan 0.05 
L-Tyrosine 0.83 
DL-Valine 0.85 
VITAMINS: in |iM 
DL-Ca pantothenate 1.01 
Choline chloride 3.58 
Folic acid 1.05 
i-Inositol 5.55 
Nicotinamide 4.09 
Table 2 fContinuedV 
Pyiidoxine HCl 2.43 
Riboflavin-5'-phosphate, sodium 0.13 
Thiamine monophosphate 1.48 
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RESULTS 
FMRFamide reduces the magnitude of the PSC in response to action potentials 
Over the course of two days in culture, a unidirectional chemical synapse forms between 
neuronal somata of neurons B5 and B19. The presence of a chemical connection can be 
detected with electrophysiological techniques. The voltage of the presynaptic neuron was 
monitored with a microelectrode and a patch pipette was used to record current from the 
postsynaptic neuron. Action potentials in the presynaptic neuron evoke the release of 
neurotransmitter that causes chloride-dependent postsynaptic currents (PSCs) in the 
postsynaptic cell. At a holding potential of -80 mV and with dialysis with 50 mM KCl fix>m 
the postsynaptic pipette, these PSCs become inward currents. Neurotransmitter is released in a 
calcium-dependent manner &om somatic synapses since calcium-deficient bathing medium 
depresses synaptic transmission (Haydon, 1988). 
The effect of the neuropeptide FMRFamide was tested on synaptic transmission. Action 
potentials were evoked in B5 at 1 minute intervals. Figure 1A shows the effect of application 
of 1 |iM FMRFamide, the standard concentration of the peptide used throughout this study. 
The pooled data from five synapses are shown in the histogram in Figure IB. In the presence 
of the peptide, the magnitude of the action potential-evoked PSC is reduced to 0.29 ± 0.10 
(mean + s.e.m.) of the control period. Following washout of FMRFamide, there was little 
recovery of the magnitude of the PSC. In the washout period, the PSC had a value of 0.37 ± 
0.15. The incomplete recovery of the magnitude of the PSC may be due to incomplete 
washout of the agonist or perhaps, long-lasting effects of FMRFamide. Nonetheless, 
FMRFamide has a pronounced inhibitory effect on synaptic transmission between neurons B5 
and B19. 
FMRFamide has a presynaptic locus of action 
Although it is apparent that FMRFamide reduces the magnitude of the PSC, its locus of 
action is unknown. Potential targets of the effects of FMRFamide are the presynaptic neuron, 
the postsynaptic neuron, or both sites. The locus of its action can be determined by examining 
its effects on desynchronized release. A presynaptic locus of action would be manifested by a 
decrease in the frequency of MPSCs. A postsynaptic locus would be detected as a reduction in 
the amplitude of each event although the frequency of events would remain constant A 
Figure 1. FMRFamide reduces the action potential-evoked PSC magnitude 
(A) The presynaptic neuron was impaled with a microelectrode to record and evoke action potentials. The postsynaptic neuron 
was voltage clamped at a holding potential of -80 mV with a patch pipette. Action potentials were evoked in the presynaptic 
neuron at 1 minute intervals. The current in the postsynaptic neuron in response to presynaptic action potentials is shown. 
FMRFamide (l[iM) reduces the magnitude of the PSC. (B) Histogram showing the data from 5 synapses. FMRFamide 
reduces the magnitude of the PSC. The bars represent the mean + s.e.m. 
Control FMRFamide 
• Control 
H FMRFamide 
• Wash 
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decrease in the sensitivity of postsynaptic receptors results in a smaller response in the 
postsynaptic neuron to a given quantity of transmitter. 
Both presynaptic and postsynaptic neurons were voltage clamped with patch pipettes. The 
presynaptic neuron was held at -60 mV and depolarized for 4 seconds to potentials that caused 
reliable release of neurotransmitter. Depolarization of B5 for several seconds causes a 
desynchionized release of neurotransmitter. A series of MPSCs can be seen throughout the 4 
second voltage step (Figure 2A). The amount of transmitter released in response to a long-
duration stimulus varies with the command potential. During stronger depolarizations, a larger 
population of voltage-sensitive calcium channels opens which then triggers the release of more 
transmitter as shown in Figure 2A. This desynchronized release is due to the calcium-
dependent release of ACh (Zucker and Haydon, 1988). As shown in Figure 2B, the number 
of MPSCs is reduced when the synapses were bathed in a solution that contained no added 
calcium. Release of neurotransmitter is not fully blocked in nominally calcium-free saline 
because there is still a substantial electrical gradient for calcium that can result in elevated 
internal calcium levels (Mulkey and Zucker, 1990). 
The effect of FMRFamide was tested on desynchronized release. As shown in Figure 3, 
FMRFamide reduced the number of MPSCs during a constant voltage step to 0.62 + 0.07 of 
the control period. The reduction in the frequency of MPSCs was not due to depression of the 
synapse since it subsequentiy increased to 0.85 ± 0.08 following washout (Figure 3B; 
P<0.025; 2-tailed student's t-test). The reduction in the frequency of MPSCs in the presence 
of FMRFamide is consistent with a presynaptic locus of action. 
These experiments do not exclude additional modulatory effects on the postsynaptic neuron. 
The somatic Qmapse system allows for a detailed examination of presynaptic mechanisms 
underlying synaptic plasticity. However, to confirai that FMRFamide is not exerting additional 
effects on the postsynaptic cell, ACh was applied to postsynaptic neurons. In the presence of 
FMRFamide, the magnitude of the PSC in response to ACh remained constant (Zoran et al., 
1989). 
HVA calcium current 
Neuromodulators can modulate action potential-evoked release of neurotransmitter by 
causing changes in ion conductances. Thus, the effect of FMRFamide was tested on the 
calcium currents of presynaptic neuron B5. When the cell body of neuron B5 is plated into a 
nonadhesive culture environment for two days, it retains a spherical geometry, is devoid of 
Figure 2. Desynchronized release is dependent on voltage and calcium 
(A) Presynaptic and postsynaptic neurons were voltage clamped with patch pipettes and held at -60 mV. A 4-second voltage step 
was delivered to the presynaptic neuron to evoke the desynchronized release of transmitter. This is shown in the postsynaptic 
current records as downward deflections. Each deflection represents a MPSC. Presynaptic command potentials are indicated 
next to each postsynaptic record. Steps to greater depolarized potentials evoke the release of more transmitter. (B) The 
presynaptic neuron was depolarized to -10 mV from a holding potential of -60 mV. Bathing synaptic pairs in a low-calcium 
medium reduces the release of neurotransmitter. Addition of a calcium-containing medium restores transmitter release. 
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Figure 3. FMRFamide causes a presynaptic inhibition of secretion 
(A) Presynaptic and postsynaptic neurons were voltage clamped in the whole-cell configuration. The presynaptic neuron was 
depolarized from a holding potential of -60 mV to -15 mV. This causes a desynchronized release of neurotransmitter which was 
seen as downward deflections in the current recordings from the postsynaptic cell (Ipost)- Each deflection represents a MPSC. 
Application of 1 nM FMRFamide reduces the number of desynchronized MPSCs. In the example shown, FMRFamide reduced 
the number of MPSCs from 16 to 1, (B) Histogram showing the reveraible reduction in the frequency of MPSCs caused by 
FMRFamide (n=9). The mean ± s.e.m. are shown. 
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neuiites, and gains the ability to release neurotransmitter in response to action potentials. 
Neurosecretory somata contain a High-Voltage-Activated (HVA) calcium current that is 
activated by depolarizations from a holding potential of -60 mV to about -20 mV or greater. 
This current is sustained during the 200 ms voltage pulse. 
Bath application of 1 pM FMRFamide reversibly reduced this net inward current (Figure 
4A; Man-Son-Hing et al., 1989). The effect of FMRFamide on the HVA current was 
quantified. Addition of 1 FMRFamide caused a reduction of the calcium current to 0.87 ± 
0.02 (mean + s.e.m.) of the control current magnitude value of 1.00 (Figure 4B; n=27 cells). 
The effect of FMRFamide was reversible as the calcium current increased to a significantly 
greater value of 0.96 + 0.02 following washout of the peptide (Figure 4B; n=27; PcO.OOl; 2-
tailed student's t-test). 
I have demonstrated that the HVA calcium current was specifically blocked by FMRFamide 
because: 1) as shown in the current/voltage relationship in Figure 5A, FMRFamide decreased 
the HVA current at aU command potentials; 2) the extrapolated reversal potential (the point 
where the curve intercepts the X axis) of the HVA current remained unchanged at +60 mV 
during the application of FMRFamide (Figure 5A); 3) when the magrtitude of the calcium 
current was reduced with Cd^"^, a calcium channel blocker, the extent of FMRFamide's 
reduction of the calcium current was diminished but the percent reduction remained constant 
(Figure 5B). In Figure 5B, FMRFamide caused a 0.75 nA (19%) reduction of the calcium 
current. Addition of 1 |iM FMRFamide in the presence of 50 }iM Cd2+ caused a 0.30 nA 
(18%) reduction in the current magnitude. This effect was seen consistentiy in 12 cells tested. 
Taken together, these three lines of evidence demonstrate that the HVA calcium current is 
reversibly reduced by FMRFamide. 
FMRFamide reduced the calcium current in a dose-dependent fashion (Figure 5C). 
FMRFamide caused a maximal reduction at 10"^ M and had an estimated apparent Kj of about 
10"^ M. Neurons retained the ability to respond to FMRFamide for the duration of the whole-
cell recording. Repeated applications of FMRFamide reliably reduced the calcium current 
throughout the 30 minute recording period. 
Selective action on the HVA calcium current 
Many neuronal cell types contain multiple types of calcium currents (for review, see Miller, 
1987). When neuron B5 is acutely isolated firom the nervous system, it contains two distinct 
calcium currents (day 0 in culture), a Low-Voltage-Activated (LVA) calcium current and a 
Figure 4. FMRFamide reversibly reduces the magnitude of a HVA calcium current in 
neurosecretory somata 
(A) A GTP-containing patch pipette was used to voltage clamp a secretory somata. The 
neuron was repetitively depolarized to +10 mV fiom a holding potential of -60 mV. 
Superimposed current traces show that addition of 1 pM FMRFamide reversibly reduces the 
magnitude of the inward current. The current magnitude increases following washout of 
FMRFamide. (B) Histogram showing that 1 |iM FMRFamide reversibly reduces the 
magnitude of the calcium current (n=27). The magnitude of the current is represented by the 
bars and is expressed as mean ± s.e.m. 
calcium current magnitude 
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Figure 5. FMRFamide selectively exerts its effects on a calcium current 
(A) A currcnVvoltage relationship of the HVA current is plotted. The peak magnitude of the 
current was measured in the absence (solid circles) and presence (open circles) of EMRFamide. 
The difference current (solid squares), obtained by subtracting the current present in 
FMRFamide from the control current, has a positive extrapolated reversal potential indicating 
that the calcium current is sensitive to FMRFamide. (B) B5 was depolarized to +20 mV. 
Addition of FMRFamide reduces the magnimde of the calcium current 50 |iM Cd^"*", a 
calcium channel blocker, was added to the bath to reduce the magnitude of the calcium current 
The extent of the effect of FMRFamide is reduced in the presence of Cd^"*". (C) The effects of 
FMRFamide on the HVA calcium current are concentration-dependent Values are means + 
s.e.m. from 5 to 8 cells. 
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electrophysiological properties. In acutely-isolated cells, the LVA current is selectively 
activated by depolarizations to -20 mV and decays during the 200 msec pulse (Figure 6A). The 
HVA current is activated by more positive potentials and is only partially decaying QFigure 6A). 
Figure 6B shows a current/voltage (T/V) relationship ftom an acutely-isolated neuroiL The 
presence of two currents with different activation thresholds results in a plateau at negative 
command potentials. The LVA and HVA calcium currents are also distinct with respect to their 
pharmacological properties. 10 }JiMCd2+, a calcium channel blocker, reliably reduces the . 
HVA current while having little effect on the LVA current (Haydon and Man-Son-Hing, 1988). 
50 to 100 |iM Cd^"*" is required to affect the LVA calcium current. 
To test if FMRFamide also exerts its effects on the LVA current, acutely-isolated neurons 
were repetitively depolarized to -20 mV to selectively activate LVA. Addition of 1 jxM 
FMRFamide did not cause a significant reduction in the LVA current (Figure 7A). In the 
presence of 1 ^ iM FMRFamide, the LVA current was 0.98 ± 0.04 of the control current 
magnitude (n=8). The effect of FMRFamide on the HVA current in such acutely isolated cells 
was also tested. A prepulse to -20 mV was delivered to inactivate LVA so that a depolarization 
step to +20 mV selectively activated the HVA current. While the LVA calcium current was 
unaffected, the HVA current in the same cell was reduced by FMRFamide to 0.80 ± 0.04 of 
the control current (n=8; Figure 7A). Thus, the effect of FMRFamide on the macroscopic 
calcium current is selective. 
Secretory apparatus 
In nonneural cells, G proteins and second messengers directiy control the secretory 
machinery by affecting its sensitivity to the internal level of free calcium (Haslam and 
Davidson, 1984). To determine if FMRFamide has effects on the secretory machinery of 
neuron B5, in addition to and separate from its effects on the calcium current, the secretory 
machinery had to be experimentally separated from voltage-dependent ion conductances. For 
this purpose, the photolabile calcium cage, nitr-5 (see Materials and Methods; Adams et al., 
1988), was used to stimulate secretion independentiy of all voltage-sensitive ion channels. 
The presynaptic and postsynaptic neurons were voltage clamped with patch pipettes and 
held at -80 mV. Nitr-5 was included in the pipette of the presynaptic cell to dialyze into the 
cytoplasm. After allowing 1 to 5 minutes for dialysis, the neurons were exposed to 340 nm 
light to photolytically release calcium from nitr-5. In this manner, the level of intracellular free 
calcium was raised to promote the secretion of neurotransmitter from the presynaptic neuron. 
Figure 6. Acutely-isolated neurons contain 2 types of calcium currents 
(A) An acutely-isolated neuron was whole-cell voltage clamped and held at -60 mV. The LVA 
calcium current is activated selectively by depolarizations to -20 mV and is a decaying current. 
At +20 mV, the HVA and LVA calcium currents arc both activated. The HVA current is more 
sustained than the LVA current (B) The neuron was depolarized in 10 mV increments from a 
holding potential of -60 mV to construct a current/voltage relationship. The plateau in the 
relationship at negative potentials indicates the presence of 2 types of calcium currents as 
labelled. 
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Figure 7. FMRFamide acts selectively on the HVA calcium cuircnt 
(A) An acutely-isolated neuron containing LVA and HVA calcium currents was whole cell 
voltage clamped. The neuron was depolarized from a holding potential of -60 mV to -20 mV to 
selectively activate the LVA calcium current. Application of 1 pM FMRFamide has no effect 
on the magnitude of this current. (B) The same neuron was depolarized from a holding 
potential of -20 mV to +20 mV to selectively activate the HVA calcium current. FMRFamide 
has a marked inhibitory effect on the magnitude of the HVA current 
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Photolysis caused a sustained increase in the frequency of MPSCs (Figure 8A). As shown in 
Figure 8B, synaptic transmission under such calcium-clamped conditions is reduced by 
application of the cholinergic antagonist, tubocuraiine. Synapses that had been dialyzed with 
nitr-5 containing no calcium were exposed to ultraviolet light There was no increase in the rate 
of release indicating that the elevation of MPSC frequency observed after ultraviolet 
illumination of nitr-5/calcium was due to a calcium-dependent release of transmitter rather than 
to photoproducts of nitr-5 or the ultraviolet light itself (Figure 8C; n=4). 
To test the effect of FMRFamide on secretory machinery, nitr-5 was photolyzed to increase 
the MPSC frequency. Subsequently, FMRFamide was rapidly applied extracellularly by 
pressure ejection from a pipette for a 5 to 10 second period. Fast green, an inert dye, was 
included in the FMRFamide solution to allow visualization of the application of FMRFamide. 
Addition of 1 to 10 |iM FMRFamide reliably reduced the rate of MPSCs (Figure 9A). The rate 
of release was reduced 6x)m a control value of 1.0 to 0.35 ±0.11 (Figure 9B; n=9 trials from 8 
synapses). Following washout of FMRFamide, the rate of release increased to a significantly 
greater value of 0.66 ± 0.10 (P<0.025; n=9; Figure 9B). 
Fast green in culture medium was pressure ejected onto cell pairs as a control for the 
application of FMRFamide and was found to have no effect on the rate of release (n=2). 
Additionally, FMRFamide had the same inhibitory effect on the rate of secretion in synapses 
that were bathed in a calcium-deficient medium (n=2). 
Nitr-5 is likely to be the dominant calcium buffer in the presynaptic terminal during the 
"calcium clamp" experiments. To confirm that the level of internal calcium was constant 
throughout these experiments, the fluorescent probe, fura-2, was codialyzed with nitr-5 into 
presynaptic neurons. The emission from fura-2 was monitored to obtain an indication of the 
level of free internal calcium. Neuronal pairs were exposed to ultraviolet light to photolytically 
raise the calcium level to approximately 400 nM to 1 |iM. The addition of FMRFamide did not 
change the level of calcium within the presynaptic terminal as monitored with fura-2 (n=4). 
Thus, the peptide decreased the rate of secretion from neuron B5 under conditions of constant 
internal calcium. 
Figure 8. Photolytically released calcium from nitr-5 promotes secretion. 
(A) Presynaptic neurons were dialyzed with calcium-loaded nitr-5. Traces show the MPSCs recorded from the postsynaptic 
neuron. Exposure to ultraviolet light photolytically releases calcium and the background rate of MPSCs increases. The MPSC 
frequency remains elevated after cessation of ultraviolet illumination due to the irreversible reduction in affinity of nitr-5 for 
calcium. (B) Application of tubocurarine reduces synaptic transmission. (C) Neurons were dialyzed with nitr-5 which was not 
loaded with calciimi. Ultraviolet light exposure did not increase the background rate of MPSCs demonstrating that neither 
ultraviolet light nor photoproducts of nitr-5 are responsible for elevating MPSC frequency in (A). 
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Figure 9. FMRFamide reduces the rate of MPSCs under calcium clamped conditions 
(A) Presynaptic and postsynaptic neurons were whole-cell voltage clahiped. The presynaptic neuron was dialyzed with a 
solution containing nitr-5 loaded with calcium. Ultraviolet illumination of the neurons photolytically released calcium to trigger 
an increase in the background frequency of MPSCs. Application of 1 |xM FMRFamide reduces the frequency of MPSCs. (B) 
Histogram showing the normalized MPSC rate. The average rate was measured for 3 seconds for each synapse before, during, 
and after FMRFamide application. FMRFamide reliably reduces the rate of MPSCs which partially recovered after its removal. 
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DISCUSSION 
Using an experimental system that allows direct access to the presynaptic terminal, I have 
examined two mechanisms by which a neuromodulator causes an inhibition of neurotransmitter 
release. FMRFamide reduced the amount of transmitter released through dual mechanisms. 
First, FMRFamide decreased the magnitude of the HVA macroscopic calcium current present 
in secretory membrane. FMRFamide's effects were specific in that there was no reduction in 
the magnitude of the LVA calcium current that is present with the HVA current in acutely-
isolated ceUs. The subcellular mechanisms by which FMRFamide exerts its effects on the 
calcium channels is discussed in Section 2. 
A second locus of modulation in the presynaptic neuron was revealed. Calcium was 
elevated to a constant level with a photolabile calcium cage to evoke secretion. When 
FMRFamide was applied to these calcium clamped synapses, the amount of neurotransmitter 
released decreased. Since the postsynaptic sensitivity to ACh is unaffected by FMRFamide, 
the reduced frequency of MPSCs indicates that the sensitivity of the secretory apparatus to 
calcium was reduced. There are numerous potential mechanisms by which FMRFamide could 
be affecting the secretory apparatus. One possibility is that FMRFamide is promoting the 
modification of vesicle-associated proteins. 
A model of the presynaptic terminal has been developed to account for changes seen during 
synaptic depression (Zucker, 1989). This model may also be applied to the presynaptic 
inhibition of transmitter release caused by FMRFamide. In this model, synaptic vesicles in the 
nerve terminal are divided into two spatially distinct populations. One population of the 
vesicles lies immediately adjacent to the active zone and is available for release. The other 
population of vesicles is the storage pool that is not situated at active zones. In the model, the 
storage pool replenishes the releasable pool following presynaptic activity. FMRFamide could 
be exerting its inhibitory actions on the releasable pool or on the mobilization of the storage 
pool to the active zone. 
FMRFamide may decrease the amount of transmitter released from the presynaptic neuron 
by reducing the size of the releasable pool through effects on vesicle-associated proteins. This 
type of modulation has been suggested from experiments in the squid giant axon (Llinas et al., 
1985). In these experiments, the state of phosphorylation of the vesicle-associated protein, 
synapsin I, can alter the release of transmitter. Injection of dephosphosynapsin I had an 
inhibitory effect on the postsynaptic potential whereas injection of calcium/calmodulin-
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dependent protein kinase n, which phosphorylates synapsin I, enhanced release. The authors 
propose that the injection of a kinase allows the vesicles to move to the plasma membrane to be 
released. Dephosphosynapsin I may prevent exocytosis by crosslinking the vesicles to the 
cytoskeleton such that they are unavailable for exocytosis. 
Morphological studies examining the size of the releasable pool of vesicles have been 
performed in Apfysia (Bailey and Chen, 1988). These studies show that the population of 
vesicles immediately adjacent to the active zone is dynamic. The active zone may be a 
morphologically distinct region in some synapses. Vesicles fuse with the plasma membrane in 
this region. Following habituation training, the percent of vesicles in the active zone that are 
available for release in sensory neurons decreased when compared to nerve terminals that did 
not undergo training. The authors speculate that long-term habituation may involve a reduction 
in the vesicle mobilization process. 
Alternatively, FMRFamide could exert effects on the releasable pool by affecting the release 
process itself. Proteins directly involved in the secretory event could be modified. A model 
involving a "fusion pore" in the exocytotic event has been proposed (reviewed in Aimers, 
1990). Although the molecular composition of the presynaptic active zone is completely 
unknown (Kelly, 1989), this model involves the docking of vesicles at the plasma membrane at 
specific sites via a protein(s). Binding of calcium to these proteins triggers a conformational 
change, resulting in the formation of an open pore that connects the vesicle lumen and 
extracellular space. The contents of the vesicle can escape through the pore. The pore 
gradually dilates and eventually the vesicle and plasma membranes merge, fully releasing the 
vesicle contents. FMRFamide may reduce the number of fusion pores capable of opening in 
response to calcium. 
FMRFamide could also have effects on the process of vesicle replenishment in the active 
zone, that is, the mobilization of the storage pool. This situation would be analogous to the 
model involving synaptic depression. This reduction in transmitter release following sustained 
presynaptic activity may indicate a limited store of releasable transmitter. Once depleted, this 
pool of vesicles requires time to be replenished from the storage pool (Zucker, 1989). 
FMRFamide may prevent the movement of vesicles fixjm the storage pool to the active zone, 
perhaps through vesicle/cytoskeleton interactions. 
The dual regulation of transmitter release may allow FMRFamide to have a greater range of 
inhibitory effects on neurotransmitter release. In separate studies, Haydon et al. (1991) have 
determined that the inhibition of the presynaptic calcium current and the secretory machinery 
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differ in their dose responses to FMRFamide in that the secretary machinery is inhibited at 
doses that do not aâect the calcium current At higher concentrations, both the calcium current 
and the secretory apparatus are affected by FMRFamide which may result in a greatly enhanced 
inhibitory effect on secretion. 
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SECTION 2. MODULATION OF THE HVA CALCIUM CURRENT BY FMRFamide IS 
MEDIATED BY A PERTUSSIS TOXIN-SENSmVE G PROTEIN AND 
MIMICKED BY MICROINJECTION OF THE a-SUBUNTT OF Go2 
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INTRODUCTION 
Neuromodulators of synaptic transmission can act through a variety of messenger systems 
to modulate ionic currents and cause changes in excitability and synaptic transmission. There 
is increasing evidence that G proteins play an important role in mediating agonist modulation of 
potassium, calcium, and sodium channels (for review, see Dunlap et al., 1987; for example, 
Pfaffinger et al., 1985, Holz et al., 1986, Hescheler et al., 1987, Nakajima et al., 1988; 
Schubert et al., 1989; Toselli and Lux, 1989). 6-Adrenergic stimulation of dihydropyridine-
sensitive calcium chaimels is mediated by phosphorylation via cAMP-dependent protein kinase 
(Kameyama et al., 1986) and by a direct action of Gg on the channel (Yatani et al., 1987, 
1988). A variety of agonists have been shown to inhibit voltage-dependent calcium channels 
via Gi - or Go-mediated processes (for reviews, see Rane and Dunlap, 1990 and Hescheler et 
al., 1990). The demonstration of two forms of Go (Scherer et al., 1987; Goldsmith et al., 
1988) that arise 6om alternate splicing of a single gene product (Hsu et ai., 1990; Strathmann 
et al., 1990) raises the question as to whether both forms of Go couple to the same or different 
effector systems. Gq has been shown to couple the stimulation of phospholipase C (Kikuchi et 
al., 1986; Moriarty et al., 1990) as well as inhibition of calcium channel activity. 
In an attempt to determine the mechanism(s) by which FMRFamide reduces a calcium 
current in cultured Helisoma neurons and whether the different molecular forms of Gq 
demonstrate effector specificity, I analyzed some of the actions of guanine nucleotides, 
pertussis toxin (PTX) and purified G proteins on the FMRFamide-mediated reduction of the 
HVA calcium current Using whole-cell voltage clamp and microinjection, I demonstrate that 
FMRFamide reduces the magnitude of a HVA calcium current through a PTX-sensitive G 
protein. Additionally, the reduction of the action potential-evoked PSC was found to be 
mediated by a pertussis toxin-sensitive G protein. Finally, I show that the activated a-subunit 
of Go2. but not of GqI, reduces the magnitude of the HVA calcium current 
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MATERIALS AND METHODS 
Cell Culture 
Individual identified neurons were isolated using standard techniques (Haydon et aL, 1985; 
Haydon, 1988; Haydon and Man-Son-Hing, 1988). Briefly, buccal ganglia were acutely 
isolated from the animal and enzymatically treated for 25 minutes in 0.2% trypsin (type m, 
Sigma Chemical Company, St Louis, MO), A small cut was made in the connective sheath 
overlying neuron B5 with an electrolytically-shaipened tungsten microknife. The neuron was 
removed from the ganglion with suction from a fire-polished glass pipette. In initial 
experiments to study somatic calcium currents, neurons were plated into a nonadhesive 
environment. The isolated neuron was plated into a 50 pi culture well containing 10% 
unfiltered snail hemolymph in Helisoma defined medium (50% Leibowitz-15 with Helisoma 
salts; GIBCO) or into a bovine serum albumin-coated culture well containing brain-conditioned 
medium (Wong et al., 1981). In both cases, adhesion to the substratum and subsequent 
neurits extension were prevented and the neurons maintained a spherical geometry. Under 
these conditions, the somata gain the ability to release neurotransmitter in response to action 
potentials (Haydon, 1988). The culture medium was changed daily. After two days of 
culture, the cells were transferred to a Falcon #1008 dish for immobilization and the calcium 
currents of secretory neuronal somata were examined. 
In some experiments, synapses were studied. Neurons B5 and B19 were isolated as 
described above. Synaptic partners were made to irreversibly contact in the culture well. A 
unidirectional chemical synapse forms after two days in culture. 
In some experiments, the calcium currents of growth cones were examined. Neuron B5 
was plated into a poly-L-lysine coated Falcon #1008 dish containing defined medium. The 
soma and its original adjoining axon rapidly adhered to the substratum. Within hours, a large 
growth cone (up to 50 pM length) formed at the axon terminal. The axon was severed with a 
micropipette to physically isolate the growth cone and the macroscopic calcium currents were 
examined. Successful recordings were obtained from 18 of greater than 250 growth cones 
attempted. The remainder of the growth cones were not viable. 
Voltage Clamp 
The calcium currents of neurosecretory, day two B5 somata were examined with whole-cell 
patch clamp techniques (Hamill et al., 1981). The cells were transferred to Falcon #1008 
55 
dishes to immobilize the cells for electrophysiological recording. Calcium currents were 
pharmacologically and ionically isolated for study with a standard external saline consisting of 
(in mM): 0 NaQ, 4.1 CaCl2,1.5 MgCl2,1.7 KCl, 30 tetraethylammonium (TEA) Br, 10 4-
aminopyridine, 10 HEPES, and 30 sucrose (pH 7.3 with TEA OH). 
Patch pipettes had resistances of 2 MO when filled with an internal saline containing (in 
mM): 35 CsQ, 5 Mga2,5 EGTA, 5 HEPES, 1 OTP (tris salt) (pH 7.3 with CsOH). The 
internal solution usually contained 5 mM ATP (Na+ salt); similar results were obtained with or 
without ATP. Neurons were voltage clamped using a Dagan 89(X3 patch clamp amplifier and 
signals were filtered with a comer frequency of 1 kHz. In all figures, leakage and capacitative 
currents have been digitally subtracted using appropriately scaled hyperpolarizing pulses. 
Series resistance compensation was employed. 
When the effect of FMRFamide (Bachem Inc.) on the calcium current was studied, a 
standard stimulus paradigm was used. Neurons were repetitively depolarized at 30 second 
intervals for nine episodes from a holding potential of -60 mV to a command potential that 
evoked the maximum current in an individual cell. The current magnitude was monitored for 
three depolarizations in standard external saline to ensure the stability of the current If the 
peak calcium current decreased by >5% in this time period, analysis of the cell was terminated. 
If the current remained stable, the average magnitude of the control HVA current evoked by the 
three depolarizations was assigned a value of 1.0. The mean peak calcium current from three 
depolarizations in 1 |iM FMRFamide, and the mean peak current from three depolarizations 
following washout of the peptide, were calculated and normalized to the control value of 1.0. 
Differences were tested using 1- and 2-tailed student's t-tests. The values expressed are the 
mean ± s.e.m. unless otherwise stated. Unless stated otherwise, 1 }xM FMRFamide was used 
throughput the experiments. 
During electrophysiological recordings from synapses, the culture wells were filled with 
DM or 1 }JM FMRFamide in DM Postsynaptic neurons were voltage clamped using Dagan 
Corporation 8900 patch amplifiers. Postsynaptic pipettes contained (in mM): 50 KCl, 5 
MgCl2,5 EGTA, 5 K+HEPES, pH 7.3 and typically had resistances of 4 MQ. 
Action potentials were evoked in the presynaptic neuron to stimulate secretion using 
microelectrodes with resistances of 10 to 40 MQ when filled with 1.5 M KCl. The 
microelectrodes were connected to a Getting Model 5A amplifier. To quantify the effect of 
FMRFamide on action potential-evoked release, the experiment was divided into three periods: 
before the addition of FMRFamide, in the presence of FMRFamide, and following washout of 
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FMRFamide. In each synapse in the period before addition of FMRFamide, the amplitude of 
thî three evoked postsynaptic currents (PSCs) were averaged and normalized to a value of 1.0. 
The amplitude of the three PSCs in the presence of FMRFamide, and the three PSCs following 
washout of FMRFamide were averaged and compared to the control value of 1.0. 
Chemicals 
To test for the involvement of arachidonic acid metabolites in the mediation of 
FMRFamide's action on the calcium current, stock solutions of arachidonic acid (Sigma) and 
nordihydroguaiaretic acid (NDGA; Sigma) were made in DMSO at concentrations of 10 mM 
and 1 mM respectively. Stock solutions were diluted in standard external saline to yield final 
concentrations of 50 pM arachidonic acid and 5 |iM NDGA. 
When the involvement of G proteins in FMRFamide's action on the calcium current was 
tested, guanine nucleotide derivatives replaced GTP in the following concentrations: 1(X) pM 
GTPyS (guanosine-5'-0-(3-thiotriphosphate), Boehringer Mannheim Biochemicals); 100 pM 
Gpp(NH)p (5'-guanylyl-imidodiphosphate, Sigma); 500 |iM, 2 mM, and 5 mM GDPfiS 
(guanosine 5'-0-(2-thiodiphosphate), Boehringer Mannheim Biochemicals). 
Pertussis toxin A protomer (List Biological Laboratories, Inc.) was made up to a final 
concentration of 0.1 Hg/|il in normal internal solution that also contained 20 mM dithiothreitol, 
20 mM NAD+» and 5 mM ATP. The toxin was pressure injected into neuronal somata with 
beveled microelectrodes. 
All G proteins and a-subunits were kindly provided by Dr. Juan Codina. The purified 
activated a-subunits were diluted to 50 nM in a buffer containing (in mM): 10 TrisHCl, 1 
EDTA, 1 dithiothreitol, 7.5 MgCl2,20 KCl and stored at -70®C. Immediately prior to use, the 
a-subunits were diluted with buffer to 5 nM or 10 nM. 
G proteins and pertussis toxin were pressure injected using a Picospritzer II (General Valve 
Corporation). The final concentration of a-subunits in the neuron was estimated by 
perfomûng parallel microinjections of fluorescein (Molecular Probes). The fluorescence of the 
cell following the microinjection was compared to a standard curve constructed from the 
fluorescence of known concentrations of fluorescein. Using this method, I estimate the 
dilution of the a-subunits to be l(X)-fold following microinjection. 
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RESULTS 
Arachidonic acid 
In Aplysia sensory neurons, FMRFamide increases the probability that a class of potassium 
channels, the "S" channels, are in an open state (Belardettr et al., 1987). The effects of 
FMRFamide on sensory neurons have been found to be mediated by lipoxygenase metabolites 
of arachidonic acid (Piomelli et al, 1987). In addition, arachidonic acid has been implicated in 
G protein activation of cardiac potassium channels (Kurachi et al, 1989; Kim et al, 1989). 
Therefore, to test for the involvement of a similar pathway in mediating FMRFamide's effect 
on the HVA current in Helisoma, 50 pM arachidonic acid was bath applied to the neurons 
(Figure 1 A). In 11 cells tested, arachidonic acid did not change the magnitude of the calcium 
current Furthermore, the inhibitors of arachidonic acid metabolism, indomethacin (5 pM; 
Figure IB; n=6) and nordihydroguaiaretic acid (5 |iM; Hgure IC; n=7), did not prevent the 
FMRFamide-evoked reduction of the HVA calcium current FMRFamide alone caused a 17% 
reduction in the calcium current in the neuron shown in Figure 1. In the presence of 
indomethacin and NDGA, FMRFamide caused a 16% and a 17% reduction of the calcium 
current, respectively. To ensure that arachidonic acid and NDGA were fully dissolved, 
additional experiments were performed using DMSO as the solvent In three cells tested, 
arachidonic acid did not reduce the magnitude of the current NDGA did not prevent 
FMRFamide from exerting its effect (n=3). Furthermore, arachidonic acid does have 
modulatory effects on the secretory apparatus (J. Richmond, unpublished observations). 
Thus, under conditions of whole-cell recording, arachidonic acid does not contribute to the 
FMRFamide-induced reduction of the HVA calcium current 
Guanine nucleotides 
In many cell types, it has been shown that pertussis toxin-sensitive G proteins couple 
inhibitory transmitters to calcium currents (for example, Holz et al.,1986; Lewis et al.,1986; 
Dolphin and Scott, 1987; Hescheleret al., 1987; Wanke et al., 1987; Ewald et al., 1988 ; 
Harris-Warrick et al., 1988; Ewald et al., 1989; Toselli and Lux, 1989). In neurons that were 
diaiyzed with GTP, FMRFamide caused a reversible reduction in the magnitude of the calcium 
current (Figure 2A). In 27 neurons, FMRFamide reduced the current magnitude by an average 
value of 13% (Figure 2B). Neurons diaiyzed with a solution that did not contain GTP retained 
their responsiveness to FMRFamide throughout the recording period. The involvement of a G 
Figure 1. Arachidonic acid metabolites do not mediate the actions of FMRFamide on 
the HVA calcium current 
(A) A secretory somata was voltage clamped at a holding potential of -60 mV and repetitively 
depolarized to +20 mV. Superimposed current traces show that application of 50 jiM 
arachidonic acid does not reduce the calcium current magnitude. Neither of the inhibitors of 
arachidonic acid metabolism, indomethacin (Indo; B; 5 pM) nor nordihydroguaiaretic acid 
(NDGA; C; 5 |JM) prevent FMRFamide fiom exerting its inhibitory effects on the calcium 
current. 
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Figure 2. EMRFamide reversibly reduces the magnitude of a HVA calcium current in 
neurosecretory somata 
(A) A secretary soma was dialyzed with 1 mM GTP and repetitively depolarized to +10 mV 
from a holding potential of -60 mV. Superimposed current traces show that addition of 1 |iM 
FMRFamide reversibly reduces the magnitude of the inward current. The current magnitude 
increases following washout of FMRFamide. (B) Histogram showing that 1 |XM FMRFamide 
reversibly reduces the magnitude of the calcium current (n=27). The magnitude of the current 
is represented by the bars and is expressed as mean + s.e.m. 
FMRFamide promotes an irreversible reduction in the calcium current magnitude when cells 
were dialyzed with 100 ^M GTPyS (C; n=8) and 100 |iM Gpp(NH)p (D; n=6). (E) After 30 
minutes of dialysis with 500 ^iM GDPgS, FMRFamide's action on the calcium current is 
blocked (n=4). 
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protein in mediating the reduction of the HVA current by FMRFamide was tested by 
substituting the guanine nucleotide derivatives Gpp(NH)p, GTPyS, or GDPfiS for GTP in the 
pipette solution. 
Nonhydrolyzable GTP analogues irreversibly activate G proteins. In the absence of 
agonist, these analogues can slowly activate the endogenous G proteins. I used the agonist, 
FMRFamide, to promote GDP/GTPyS exchange to accelerate G protein activation and then 
determined whether the action of FMRFamide was irreversible under this experimental 
condition. With 100 p.M GTPyS in the pipette solution, FMRFamide (1 pM) decreased the 
calcium current magnitude to 0.79 + 0.03 of the control value (Figure 2C; n=8). In contrast 
to the results from cells containing GTP, this reduction was irreversible as the calcium cuirent 
remained at the value of 0.78 ± 0.05 after washout of the peptide (Hgure 2C). This value is 
significantly different from the washout value of0.96 + 0.02 in GTP-containing cells (P-
value<0.002; 1-tailed t-test). Similar results are shown in Figure 2D with 100 nM Gpp(NH)p 
dialyzing the cells. FMRFamide caused a decrease in the calcium current magnitude to 0.81 ± 
0.03 which did not recover following washout (0.76 + 0.03; n=6). Following washout of 
FMRFamide, the calcium current magnitude in GTP-containing cells was significantly different 
from the Gpp(NH)p-containing cells (P value<0.(XX)5; 1-tailed t-test). 
Additional evidence for the involvement of a G protein in mediating the action of 
FMRFamide is that a second application of the peptide to GTPyS-containing cells did not cause 
a further reduction in the HVA current (n=5). This indicated that the first application of 
FMRFamide promoted maximal, irreversible G protein activation. 
The results from the previous experiments involving GTP analogues indicate that a G 
protein is involved in mediating FMRFamide's action on the calcium current. To further test 
this hypothesis, the GDP analogue, GDPfiS, which competes with GTP for the guanine 
nucleotide binding site and prevents G protein activation, was included in the patch pipette 
solution. 
The effect of FMRFamide was blocked in a time- and dose-dependent fashion with GDPfiS 
dialyzing the cell. FMRFamide reduced the calcium current during the initial 15 minutes of 
dialysis with 500 ^M GDPgS in the pipette solution. Later, the extent of the reduction caused 
by FMRFamide became attenuated until the effect was completely blocked. As shown by the 
pooled data in Figure 2E, the HVA current remained unchanged at a value of 1.0 + 0.10 during 
the application of FMRFamide after 30 minutes of dialysis with GDPfiS (n=4). The effect of 
FMRFamide was blocked immediately when higher concentrations of GDPfiS were included in 
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the pipette solution (2 to 5 mM). The first application of FMRFamide did not reduce the 
magnitude of the HVA current (1.05 ± 0.06; n=4). Taken together, these data are consistent 
with the involvement of a G protein in mediating FMRFamide's reduction of the HVA current 
Pertussis toxin 
To begin to identify the FMRFanoide-activated G protein, the PTX A protomer was added 
to the interior of the cell by pressure injection through a beveled microelectrode. Cells were 
allowed to incubate for 4 to 18 hours before voltage clamping. As shown in Figure 3A, 
FMRFamide had little effect on the magnitude of the calcium current in a PTX-treated cell. 
FMRFamide decreased the magnitude of the calcium current in PTX-injected cells to 0.97 + 
0.02 of the control current (n=7) and in heat-inactivated PTX-injected cells to 0.71 + 0.02 
(n=ll; Figure 3B). The effects of cholera toxin were not tested. Thus, a PTX-sensitive G 
protein is a component of the FMRFamide signal transduction pathway in reducing the 
magnitude of the somatic calcium current. 
PTX prevented FMRFamide from modulating svnaptic transmission 
Since the effects of FMRFamide on the HVA calcium current and on the secretory 
machinery (Haydon et al., 1990) appear to be mediated by a PTX-sensitive G protein, I tested 
whether a PTX-sensitive G protein is also involved in the modulation of action potential-
evoked synaptic transmission. Presynaptic somata were injected with the A protomer of PTX 
4 hours prior to recording. As shown by the PSC traces in Figures 4A and 4C, FMRFamide 
had litde inhibitory effect in PTX-treated synapses but did reduce the PSC magnitude in control 
synapses. In PTX-treated synapses, FMRFamide reduced the PSC magnitude from 1.0 to 
0.88 ± 0.09 (n=5; Figure 4B). In control preparations that had been preinjected with heat-
inactivated toxin, the PSC magnitude was reduced to 0.35 ± 0.09 (n=5; P<0.002; 2-tailed t 
test; Figure 4D). PTX-sensitive G proteins appear to be involved in mediating the effects of 
FMRFamide on both a voltage-sensitive calcium current and on action potential-evoked release 
of transmitter. 
Growth cones 
Transmitter release characteristically occurs from neuronal processes rather than from 
somata. Haydon and Zoran (1989) have demonstrated that FMRFamide causes presynaptic 
inhibition of transmitter release at synapses formed by growth cones of B5. Growth cones 
Figure 3. FMRFamide's action on the calcium current is mediated by a PTX-sensitive 
G protein 
Superimposed current traces were obtained from neurons which had been injected 4 to 18 
hours eadier with either PTX (A) or heat-inactivated PTX (B). (A) FMRFamide did not cause 
a reduction in the magnitude of the calcium current in a soma injected with PTX. (B) 
FMRFamide decreases the calcium current of a heat-inactivated PTX-treated soma. (Q 
Histogram showing the percent reduction in the calcium current magnitude by 1 |iM 
FMRFamide in PTX- (n=7) and heat-inactivated PTX-treated (n=l 1) neurons. 
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The A protomer of PTX (A) or heat-inactivated PTX (C) was preinjected into the presynaptic neuron. Single traces of action 
potential-evoked PSCs were obtained before and after FMRFamide addition. (B) PTX pretreatment prevents FMRFamide from 
reducing the magnitude of the PSC. (D) Heat-inactivated PTX does not prevent FMRFamide from decreasing the PSC 
magnitude. 
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contain a HVA calcium current that is similar electrophysiologically and phaimacologically to 
the HVA current in somata (Haydon and Man-Son-Hing, 1988). To determine whether 
FMRFamide has a similar action on calcium currents in growth cones as in secretory somata, a 
limited number of experiments were performed on growth cones (see Materials and Methods). 
Growth cones were physically isolated from the remainder of the cell and were then voltage 
clamped in the whole ceU mode (see Haydon and Man-Son-Hing, 1988). Hguie 5A shows 
that the growth cone HVA calcium current was reversibly reduced by FMRFamide when GTP 
was included in the pipette solution. The magnitude of the current was reduced to 0.75 ± 0.04 
of the control current (n=3). As in somata, the reversal potential of the calcium current was not 
changed by FMRFamide and addition of Cd^"*" decreased the extent of the action of 
FMRFamide but the percent reduction remained unchanged. Thus, FMRFamide reduces the 
HVA calcium current of growth cones as well as secretory somata. 
To test if this reduction is mediated by G proteins, guanine nucleotide derivatives were 
included in the pipette solution. When 100 pM GTPyS or 100 |iM Gpp(NH)p (Figure 5B) 
were dialyzed into growth cones, FMRFamide caused an irreversible reduction in the calcium 
current magnitude. With GTPyS in the pipette solution, FMRFamide decreased the calcium 
current to 0.76 ± 0.08 of the control current magnitude and the current remained reduced (0.77 
± 0.08) following washout of the peptide (n=3). With Gpp(NH)p, the current was decreased 
to 0.57 ± 0.12 of the control current upon application of FMRFamide and further declined to 
0,48 ± 0.20 after washout (n=3). GDPgS (5 mM) prevented FMRFamide from reducing the 
calcium current (Figure 5C; n=3). The calcium current changed minimally to 1.02 ± 0.05 of 
the control current magnitude in the presence of FMRFamide Due to the fragility of growth 
cones under recording conditions, the higher concentration of 5 mM GDPfiS was used to see 
an immediate effect 
To determine whether a pertussis toxin-sensitive G protein mediates the action of 
FMRFamide on growth cone calcium currents, the A protomer was injected into the cell body 
and allowed to diffuse to the growth cone for 12 hours prior to severing the axon. 
Pretreatment with pertussis toxin prevented FMRFamide from reducing the calcium current 
(Rgure 5D; n=3). Application of FMRFamide caused an insignificant change in the calcium 
current magnitude to 1.04 + 0.02 of the control value. In growth cones pretreated with heat-
inactivated pertussis toxin, FMRFamide reduced the magnitude of the current to 0.64 + 0.12 of 
the control current (n=3). Thus, in growth cones that release neurotransmitter, FMRFamide 
Figure 5. The effect of FMRFamide on the HVA calcium current in growth cones is 
mediated by aPTX-sensitive growth cone 
Isolated growth cones were voltage clamped at -60 mV and depolarized to +10 or +20 mV and 
the resulting current traces are superimposed. (A) In a GTP-containing growth cone, 
FMRFamide reversibly reduces the magnitude of the HVA calcium current (B) FMRFamide 
irreversibly decreases the magnitude of calcium currents in growth cones dialyzed with 
Gpp(NH)p. (C) GDPBS prevents FMRFamide firom reducing the magnitude of the current 
(D) Pretreatment with FIX abolishes the action of FMRFamide on the calcium current 
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acts through a pertussis toxin-sensitive G protein to decrease the HVA calcium current in a 
manner similar to that more rigorously tested in secretory somata. 
Introduction of exogenous G proteins 
To determine which G proteins are able to couple FMRFamide to the inhibition of the 
calcium current, purified heterotrimeric G proteins were introduced into cells that had been 
previously treated with FIX. After ensuring that the endogenous G proteins were inactivated 
by the toxin, the purified G protein was microinjected into the cell and the effect of 
FMRFamide on the calcium current was tested 3 to 25 minutes following injection. Addition 
of 5 or 10 nM GqI (n=6), Go2 (n=6) and Gi2 (n=4) did not reconstitute the effect of 
FMRFamide. 
Previous studies have shown that G protein a-subunits can directly activate potassium 
channels (Yatani et al., 1987, 1988) and reconstitute agonist inhibition of calcium channels 
(Ewald et al., 1989). Therefore, I injected purified, preactivated G protein a-subunits into 
secretory somata to determine their effects on whole-cell calcium currents. 
Injection of the GTPyS-activated cc-subunit of Go2 (Oo2*; 10 nM electrode concentration) 
into somata reduced the magnitude of the calcium current (Figure 6A). This effect was detected 
as soon as 30 seconds after injection, which was the time of the first voltage step following 
microinjection. Subsequent injections into the same cell further reduced the calcium current 
until it was abolished. In comparison to control injections of buffer, cco2* significantiy 
reduced the current of untreated cells and cells that had been previously injected with PTX. 
Injection of (Xo2* did not significantiy reduce the LVA calcium current compared to buffer 
injection (P>0.1). 
The mean reduction in HVA calcium current per injection (± s.e.m.) was calculated for 
each cell. Buffer injection reduced the current by 4.67% ±1.17 (n=5) while oco2* injection 
decreased the current by 11.91% ± 2.82 (Figure 6A; n=9; P value < 0.05,2 tailed student's t-
test ). While oto2* injection significantiy reduced the calcium current, neither ocqI* (10 nM) 
nor ai3* (10 nM) had effects significantiy different from control injections (Figure 6A). 
Figure 6. Microinjection of the a-subunit of Go2» but not buffer, reduces the 
magnitude of HVA 
The magnitude of the HVA calcium current was measured every 30 seconds. (A) Injection of 
cxo2* (arrow) reliably decreases the magnitude of the current immediately following injection. 
(B) Injection of buffer (arrow) did not decrease the magnitude of the calcium current Current 
traces from before and after three injections are shown in the insets. Application of 
FMRFamide decreases the current magnitude both before and after the series of injections. 
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Alphao2* was diluted to concentrations of 1 and 0.1 nM and injected into cells to determine 
the threshold concentration required to reduce the calcium current Injection of 1 nM, but not 
0.1 nM, cco2* significandy reduced the current (Figure 7B). Based on fluorescein dilution 
experiments, I estimate that a volume equal to 0.01 of the total cell volume was injected. Hius, 
I estimate that the threshold concentration of OoZ* for reducing the calcium current is about 10 
pM. 
The effect of FMRFamide on the calcium current was measured both before and after 
injection of (Xo2* to determine whether the ao2*-inediated inhibition of the calcium channels 
affected the actions of FMRFamide. FMRFamide caused a 25.78 % ± 3.30 (n=9) current 
reduction before injection and 24.11% + 3.53 (n=9) following injection (Figure 7C). Thus, 
when ao2* had reduced the current magnitude, FMRFamide still had the same relative effect 
on the current indicating that the same subpopulation of calcium channels is susceptible to 
FMRFamide and ao2* inhibition. (In these experiments FMRFamide reduced the calcium 
current to an extent greater than that shown in Figure 2B. The source of the variability is 
unknown.) 
To further determine if FMRFamide and (Xo2* are acting on the same population of calcium 
channels, difference currents were obtained for FMRFamide and cxo2* mediated current 
inhibition by digitally subtracting control currents from the current following experimental 
perturbation. Normalized difference traces following addition of FMRFamide and ao2* fully 
supoimposed. Taken together, these data suggest that FMRFamide and 0to2* injections target 
the same population of calcium channels. 
Figure 7. The effect of 0to2* injection is significantly greater than buffer, ccol*, and ai3* 
(A) Histogram of the % reduction of the calcium current magnitude following injection of 
buffer (n=5),aol* (n=8), ao2* (n=9), and aiS* (n=6). (B) Histogram of the % reduction in 
the calcium current magnitude caused by injection of buffer (n=5), 0.1 nM ao2* (n=5), 1 nM 
(Xo2* (n=5), and 10 nM ao2* (n=9). Injection of 1 nM and 10 nM significantly reduced the 
current magnitude while 0.1 nM had no significant inhibitory effect (P>0.10). (C) The extent 
of FMRFamide's effect is similar before (n=9) and after (n=9) injection of ao2* (as shown in 
Figure 6A). 
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DISCUSSION 
In the present study, the involvement of a G protein in the reduction of the calcium current 
was demonstrated in e^riments using guanine nucleotide analogues. In the presence of 
nonhydrolyzable GTP analogues, GTPyS or Gpp(NH)p, FMRFamide's action on the calcium 
current was irreversible. GDPfiS blocked the effects of FMRFamide. Relatively high 
concentrations of GDPgS (500 jiM to 5 mM) were required to completely block FMRFamide's 
effect This may be due to a low afiSnity of the G protein having for GDPgS, thus requiring 
high concentrations to effectively compete with GTP for binding. Additionally, all of the G 
proteins have to be inactivated by GDPfiS for FMRFamide's effect to be blocked. Volterra and 
Siegelbaum (1988) have shown that in Aplysia sensory neurons, the two different G proteins 
involved in mediating the effects of serotonin and FMRFamide have different sensitivities to 
prolonged intracellular injection of GDPfiS. The G protein involved in the FMRFamide 
response is two orders of magnitude less sensitive to the blocking effect of GDPjjS. 
In addition to preventing FMRFamide fiom exerting its inhibitory effects on calcium 
currents, pertussis toxin reduced FMRFamide's effects on action potential-evoked secretion. 
Thismay be due entirely to the lack of modulation of the calcium current Alternatively, a 
similar class of G proteins may be involved in the modulation of another site in the presynaptic 
terminal such as the secretory machinery. G proteins are involved in the process of exocytosis 
from nonneural cells (Gomperts, 1990). Perhaps this is also the case in neurons. 
Although a key role for a PTX-sensitive G protein in the FMRFamide signal transduction 
pathway has been demonstrated in my experiments, it remains to be established which 
endogenous G protein is involved. Calcium currents in another snail. Helix, are decreased by 
dopamine and this effect is mimicked by exogenously supplied mammalian OQ (Harris-Warrick 
et al., 1988). Helix nervous tissue contains a G protein that is sensitive to PTX and is 
recognized by a bovine anti- Oo- Injection of anti- a© prevents dopamine from reducing the 
calcium current Muscarinic inhibition of the HVA calcium current in PTX-treated 
hippocampal neurons is reconstituted by dialysis with the a subunit of GQ or with the 
holoprotein GO (Toselli et al., 1989). Calcium currents are not inhibited exclusively by GQ. 
Hescheler et aL (1987) demonstrated that both Go and Gi can reconstitute the inhibitory effect 
of the opioid peptide DADLE on calcium currents in neuroblastoma x glioma hybrid cells. Go 
is, however, 10 times more potent than Gi in mediating such reconstitution. Similarly in 
hippocampal cells, Gj can reconstitute muscarinic calcium current inhibition, although G© 
78 
performs this reconstitution more effectively (Toselli et al., 1989). Ewald et al. (1989) have 
shown that Oo, an, and ai2 individually can partially reconstitute bradykinin's inhibitory 
effect on calcium currents in rat dorsal root ganglia but the combination of OQ plus ai2 was 
required to fully reconstitute the effect Interestingly, in these same studies, OQ was more 
effective than ail and ai2 was almost ineffective in reconstituting neuropeptide Y-mediated 
inhibition. Furthermore, recent studies by Linder et al. (1990) using recombinant proteins 
expressed in c<?//indicate that recombinant ao. an, and ai3, but not ai2 reconstitute 
neuropeptide Y-mediated inhibition of calcium currents in rat dorsal root ganglia while all four 
recombinant proteins reconstitute bradykinin-mediated inhibition. 
Studies by Haydon and Man-Son-Hing (1988) and Haydon and Zoran (1989) have shown 
that growth cones of B5 can release neurotransmitter and that FMRFamide causes presynaptic 
inhibition of transmitter release from growth cones. As a second approach to studying the 
mechanism of presynaptic inhibition, voltage clamp studies on neuronal processes were 
performed- The effects of FMRFamide and G protein analogues are not restricted to the soma. 
The HVA current in growth cones was reduced in magnitude by FMRFamide and this process 
was also mediated by a PTX-sensitive G protein. Thus, the model system of secretory somata 
accurately reflects the properties of secretory membrane located on neuronal processes. 
Using Helisoma neurons, I have further examined the role of Go in regulating calcium 
currents. Injection of ao2* can reduce the magnitude of the calcium current and is specific for 
the HVA current Injected aol* or ai3* did not effectively decrease the calcium current 
Previous published work in which Go was able to effectively reconstitute hormonal inhibition 
was likely to have used a mixture of Gol and Go2- Thus, it is yet unknown whether calcium 
currents are differentially sensitive to Gol and Go2 in a variety of tissues and organisms. 
Studies by Moriarty et al. (1990) suggest another possibility. These authors found that Oo* 
but not an*, or ai2* or ais*, stimulates the PTX-sensitive phospholipase C-phosphatidyl 
inositol pathway inXenopus oocytes. Furthermore, Go has been shown to stimulate five 
distinct classes of potassium channels in rat hippocampal cells under conditions not thought to 
activate phopholipase C (VanDongen et al., 1988). Thus, it is possible that one isoform of a© 
couples to inhibition of calcium currents while the other couples to stimulation of 
phospholipase C or potassium channels. 
Recent molecular cloning experiments have identified two forms of a© in HIT (hamster 
insulin-secreting tumor) cells (Hsu et al., 1990) and mouse brain (Strathmann et al., 1990) 
cDNA libraries. The deduced amino acid sequence demonstrates that the expressed proteins 
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would differ in only 25 (mouse) or 26 (hamster) amino acids. These amino acid substitutions 
are located in the carboxyl third of the protein between amino acids 249 and 354. The amino 
acid substitutions largely occur within domain IQ of the a-subunit which is proposed to be the 
region involved in G protein a-subunit interactions with receptors and effectors (Masters et al., 
1988). Assuming that these two cDNAs correspond to the proteins ocol and ao2. the locations 
of these amino acid substitutions can guide future experiments designed at identifying critical 
sites for Ga-effector interaction. At the present time, I do not know which of the two forms of 
Oo identified by cloning corresponds to OQI and (Xo2 isolated fiom bovine brain. 
Additionally, there may be other forms of Ga© that can be resolved from the known forms of 
Go (Kobayashi et ai., 1989). 
My data are consistent with the hypothesis that cxo2 acts on the same calcium current as the 
peptide FMRFamide. Both agents reduce the HVA current Injection of (Xo2* reduces the 
calcium current and causes a reduction in the absolute magnitude of FMRFamide's effect, but 
leaves the percentage reduction in the current by FMRFamide unchanged. Finally, based on 
difference current analysis, ao2* and FMRFamide both reduce the HVA current that has the 
same inactivation kinetics as the control macroscopic currenL Thus, these data are consistent 
witLoco2* acting on the same target as FMRFamide, although unequivocal proof awaits single 
channel analysis. It is unknown if the injected a-subunits are acting directiy on the calcium 
channels or through second messengers. Single channel analysis will distinguish between the 
possibilities. 
It is unclear why my attempts to reconstitute the inhibitory action of FMRFamide in PTX-
treated cells with injection of heterotrimeric G proteins failed. Differences between B subunits 
of mammals and snails may have prevented effective receptor G protein interactions 
(Homburger et al., 1987). In Helisoma, I found it necessary to inject FIX into the neuron 
since bath application of the holotoxin did not uncouple FMRFamide's action on the calcium 
current Due to the concern that I may have a high concentration of FIX within the cell that 
may be rapidly ADP-ribosylating the injected G protein, I diluted FTX for injection until a 
threshold concentration was achieved. At this concentration, heterotrimeric G protein injection 
still failed to reconstitute FMRFamide's action on the calcium cunent In other studies in 
which G protein reconstitution was successful, patch pipette dialysis on small cells was used 
which leads to rapid washout of soluble intracellular proteins. Since neuron B5 is large (60|im 
diameter), dialysis of proteins is very slow. Perhaps PTX is effectively washed out of the 
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cytoplasm of the smaller cells so that added G proteins do not become ADP-ribosylated but 
sufficient PTX remains in B5 to ADP-ribosylate the injected G protein. 
In Apfysia neurons, FMRFamide decreases the amount of neurotransmitter released by 
coordinately decreasing a calcium current and enhancing a potassium current (Belardetti et al., 
1987; Brezina et al., 1987). It has been proposed that a G protein activates a phospholipase 
that generates arachidonic acid. Di Aplysia, certain presynaptic inhibitory actions of 
FMRFamide are mediated by lipoxygenase metabolites of arachidonic acid (Piomelli et al., 
1987). For example, the "S" potassium current is enhanced by application of arachidonic acid. 
Furthermore, arachidonic acid also has been implicated in G protein-mediated activation of 
mammalian cardiac potassium channels (Kurachi et al., 1989; Kim et al., 1989). In my 
studies, application of arachidonic acid had no effect on the HVA calcium current Therefore, 
in neuron B5, FMRFamide-mediated inhibition of a calcium current does not appear to involve 
phospholipase generation of arachidonic acid. 
In summary, in the present study, I have demonstrated that FMRFamide's inhibition of the 
HVA calcium current is mediated by a PTX-sensitive G protein and that the mammalian a 
subunit of Go2 can mimic the actions of FMRFamide on neuronal calcium currents. 
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GENERAL SUMMARY 
FMRFamide is a neuropeptide that is endogenous to the Helisoma nervous system (Murphy 
et ai., 1985; Bulloch et al., 1988). The actions of FMRFamide on synaptic transmission were 
studied using a system of somatic synapses. FMRFamide was found to cause a reduction in 
the magnitude of the postsynaptic current in response to presynaptic action potentials. The 
locus of FMRFamide's effects was examined- Long duration (4 seconds) voltage steps were 
delivered to the presynaptic neuron to evoke desynchronized release of neurotransmitter that 
was detected as MPSCs. Application of FMRFamide reduced the frequency of these MPSCs 
probably by a presynaptic locus of action. Postsynaptic responsiveness was also tested by 
extracellularly applying ACh in the presence and absence of FMRFamide (Zoran et al., 1989). 
The sensitivity of postsynaptic neurons to ACh remained unchanged in the presence of 
FMRFamide. Together, these two lines of evidence indicate that the presynaptic temiinal is the 
locus of FMRFamide's inhibitory action. 
The system of "giant" synaptic terminals allowed me to examine the subcellular mechanisms 
of FMRFamide in the presynaptic terminal. Since neurotransmitter release is triggered by the 
influx of calcium through voltage-dependent channels, I first examined the effect of 
FMRFamide on the presynaptic calcium current Voltage clamp studies revealed that the 
magnitude of the macroscopic HVA calcium current in the presynaptic membrane was reduced 
in the presence of FMRFamide. This inhibitory effect on calcium channels should result in a 
reduced influx of calcium into the presynaptic terminal during an action potential and a decrease 
the amount of transmitter released. Along with the calcium current, there is at least one 
additional site of action in the presynaptic terminal, the secretory apparatus. This was 
determined in experiments using a photolabile calcium cage. Presynaptic neurons were held at 
a constant, elevated level of calcium to trigger secretion of neurotransmitter. Application of 
FMRFamide to calcium clamped synapses reduced the amount of transmitter released without 
changing the intracellular calcium levels. Thus, the sensitivity of the secretory machinery to 
calcium was reduced by FMRFamide. This may be a critical site of modulation in the 
processes of learning and memory. 
I further examined the subcellular mechanisms of FMRFamide on the presynaptic calcium 
current FMRFamide has been shown to act through lipoxygenase metabolites of arachidonic 
acid in ApJysia sensory neurons (Piomelli et al., 1987). In Helisoma neurons however, neither 
arachidonic acid nor its metabolites mediate the action of FMRFamide on the calcium current 
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A pertussis toxin-sensitive G protein was found to be involved in the inhibition of the calcium 
current from studies using guanine nucleotide analogues and pertussis toxin. Nonhydrolyzable 
analogues of GTP caused FMRFanaide to irreversibly reduce the calcium current magnitude 
and the analogue of GDP, GDPGS, prevented FMRFamide from exerting its effect 
Microinjection of pertussis toxin also prevented FMRFamide from having its effects on the 
current Purified a-subunits from GQL GO2> and GI3 were microinjected into presynaptic 
somata to determine which were able to inhibit the calcium channels. Only the a-subunit of 
Go2 reduced the magnitude of the calcium current and inhibited the same population of calcium 
channels that were susceptible to the effects of FMRFamide. 
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